Bradley A. Krasnick

Autologous humanized PDX modeling for immuno-oncology recapitulates features of the human tumor microenvironment

Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms

A multi‐institutional validation study of prognostic nomograms for retroperitoneal sarcoma

Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression

Analysis of textbook outcomes among patients undergoing resection of retroperitoneal sarcoma: A multi‐institutional analysis of the US Sarcoma Collaborative

Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors

Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group

Renal Function After Retroperitoneal Sarcoma Resection with Nephrectomy: A Matched Analysis of the United States Sarcoma Collaborative Database

New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors

Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group

Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group

Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium

Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis

Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence

Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection

The role of radiation therapy and margin width in localized soft‐tissue sarcoma: Analysis from the US Sarcoma Collaborative

Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group

Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma

Nomogram predicting the risk of recurrence after curative‐intent resection of primary non‐metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group

Transplantation Versus Resection for Hilar Cholangiocarcinoma

Pathologic and Prognostic Implications of Incidental versus Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium

Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi‐institution analysis from the U.S. extrahepatic biliary malignancy consortium

Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium

Gallbladder Cancer Presenting with Jaundice: Uniformly Fatal or Still Potentially Curable?

Routine port‐site excision in incidentally discovered gallbladder cancer is not associated with improved survival: A multi‐institution analysis from the US Extrahepatic Biliary Malignancy Consortium

Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases

Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy Consortium

Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium

Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme

Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study